Literature DB >> 31509828

Prevalence and Risk of Polypharmacy among Community-Dwelling, Elderly Kuwaiti Patients.

Nabil Ahmed Badawy1, Shokria Adely Labeeb2, Mawaheb Falah Alsamdan3, Badria Faleh Alazemi2.   

Abstract

OBJECTIVES: To estimate the prevalence of polypharmacy in community-dwelling, older Kuwaiti patients, describe the number and types of drugs used, and identify risk factors associated with polypharmacy. SUBJECTS AND METHODS: This was a descriptive cross-sectional questionnaire-based survey in which we interviewed 500 community-dwelling Kuwaiti adults over 65 years of age. The data collection occurred during a 4-month period from March to July 2017.
RESULTS: Fifty-two percent (n = 260) of the patients were males, with a mean age of 71.73 ± 5.32 years. The prevalence of polypharmacy (5-8 drugs) and excessive polypharmacy (>8 drugs) was 58.4% (n = 292) and 10.2% (n = 51), respectively. The risk factors associated with an increased number of medicines used were: female gender (p = 0.019), a lower level of education (p = 0.003), a high number of hospital admissions (p = 0.000), clinics visited by the patient (p =0.000), and number of comorbidities (p = 0.000). The most commonly used medications (82.6% of the study population) were blood glucose-lowering agents, excluding insulin. Other commonly used medications were antihypertensive drugs and lipid-modifying agents.
CONCLUSION: A significant sector of the older Kuwaiti patient population has a high prevalence of polypharmacy and is thus exposed to its potential hazards. The current study highlights the need to revise the drug-dispensing policy among community-dwelling, older Kuwaiti people, as well as to initiate educational programs among healthcare practitioners concerning prescribing issues in older individuals.
© 2019 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Comorbidity; Elderly; Polypharmacy

Year:  2019        PMID: 31509828      PMCID: PMC7098304          DOI: 10.1159/000503298

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  25 in total

1.  Polypharmacy Among Adults Aged 65 Years and Older in the United States: 1988-2010.

Authors:  Christina J Charlesworth; Ellen Smit; David S H Lee; Fatimah Alramadhan; Michelle C Odden
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-03-01       Impact factor: 6.053

2.  Prevalence and predictors of co-occurring diabetes and hypertension in community-dwelling older adults.

Authors:  Omar T Sims; Hyejung Oh; Hyunjin Noh; Pamela A Melton; Samantha Sheffield; Kacey Ingram; Patricia Sawyer
Journal:  Geriatr Gerontol Int       Date:  2018-08-10       Impact factor: 2.730

3.  Potential overtreatment of diabetes mellitus in older adults with tight glycemic control.

Authors:  Kasia J Lipska; Joseph S Ross; Yinghui Miao; Nilay D Shah; Sei J Lee; Michael A Steinman
Journal:  JAMA Intern Med       Date:  2015-03       Impact factor: 21.873

4.  Factors leading to excessive polypharmacy.

Authors:  Bo Hovstadius; Göran Petersson
Journal:  Clin Geriatr Med       Date:  2012-02-15       Impact factor: 3.076

Review 5.  Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review.

Authors:  Terri R Fried; John O'Leary; Virginia Towle; Mary K Goldstein; Mark Trentalange; Deanna K Martin
Journal:  J Am Geriatr Soc       Date:  2014-12       Impact factor: 5.562

6.  Epidemiology of suboptimal prescribing in older, community dwellers: a two-wave, population-based survey in Dicomano, Italy.

Authors:  Francesco Lapi; Claudia Pozzi; Giampiero Mazzaglia; Andrea Ungar; Stefano Fumagalli; Niccolò Marchionni; Pierangelo Geppetti; Alessandro Mugelli; Mauro Di Bari
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

7.  Polypharmacy status as an indicator of mortality in an elderly population.

Authors:  Johanna Jyrkkä; Hannes Enlund; Maarit J Korhonen; Raimo Sulkava; Sirpa Hartikainen
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

8.  Prevalence and factors associated with polypharmacy in the older people: 2006-2014.

Authors:  Juan Manuel Carmona-Torres; Ana Isabel Cobo-Cuenca; Beatriz Recio-Andrade; José Alberto Laredo-Aguilera; María Manuela Martins; María Aurora Rodríguez-Borrego
Journal:  J Clin Nurs       Date:  2018-05-28       Impact factor: 3.036

9.  Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border: a descriptive, questionnaire-based study.

Authors:  Amanda M Loya; Armando González-Stuart; José O Rivera
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

10.  Prevalence and predictors of polypharmacy among Korean elderly.

Authors:  Hong-Ah Kim; Ju-Young Shin; Mi-Hee Kim; Byung-Joo Park
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

View more
  6 in total

1.  Potentially inappropriate medication use and the hospitalization rate among Thai elderly patients: a retrospective cohort study.

Authors:  Vorawee Varavithya; Chayanee Tirapat; Penpitcha Rojpibulstit; Panadda Poovichayasumlit; Vanida Prasert; Pasitpon Vatcharavongvan
Journal:  Eur J Clin Pharmacol       Date:  2022-01-29       Impact factor: 2.953

2.  Prevalence of polypharmacy and the association with non-communicable diseases in Qatari elderly patients attending primary healthcare centers: A cross-sectional study.

Authors:  Ayman Al-Dahshan; Noora Al-Kubiasi; Manal Al-Zaidan; Wael Saeed; Vahe Kehyayan; Iheb Bougmiza
Journal:  PLoS One       Date:  2020-06-11       Impact factor: 3.240

3.  Drug utilization pattern and factors associated with polypharmacy and excessive polypharmacy in geriatric medical out-patients at a rural health training centre in India.

Authors:  S Nitya; G Ramya; Sivagourounadin Kiruthika; R Meenakshi; Jayabalan Nalini Devi; Ganesan Suganya; S Pravin
Journal:  J Family Med Prim Care       Date:  2021-07-30

4.  Medication-related burden from the perspective of the elderly.

Authors:  Sayed Mahmood Alqallaf; Layan Matar; Kawthar Ghuloom; Kawthar Alabbad; Fatema Alshaikh; Mustafa Alhaddad
Journal:  Med Pharm Rep       Date:  2022-07-26

Review 5.  Deprescribing for all: a narrative review identifying inappropriate polypharmacy for all ages in hospital settings.

Authors:  Ali Elbeddini; Monakshi Sawhney; Yasamin Tayefehchamani; Zekiye Yilmaz; Ahmed Elshahawi; Josiah Josh Villegas; Janelyn Dela Cruz
Journal:  BMJ Open Qual       Date:  2021-07

6.  Age- and sex-matched comparison of diet quality in patients with heart failure to similarly aged healthy older adults.

Authors:  JungHee Kang; Debra K Moser; Martha J Biddle; GYeon Oh; Terry A Lennie
Journal:  J Nutr Sci       Date:  2021-08-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.